RCM

RA Capital Management Portfolio holdings

AUM $5.94B
This Quarter Return
+4%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$7.22B
AUM Growth
+$7.22B
Cap. Flow
+$1.18B
Cap. Flow %
16.39%
Top 10 Hldgs %
44.55%
Holding
109
New
17
Increased
12
Reduced
6
Closed
14

Top Buys

1
CLYM
Climb Bio, Inc. Common Stock
CLYM
$236M
2
IVVD icon
Invivyd
IVVD
$226M
3
CTKB icon
Cytek Biosciences
CTKB
$206M
4
ICVX
Icosavax, Inc. Common Stock
ICVX
$171M
5
DICE
DICE Therapeutics, Inc. Common Stock
DICE
$171M

Top Sells

1
AXSM icon
Axsome Therapeutics
AXSM
$112M
2
NVAX icon
Novavax
NVAX
$95.8M
3
CRIS icon
Curis
CRIS
$57.6M
4
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$56.4M
5
CCXI
ChemoCentryx, Inc.
CCXI
$56.1M

Sector Composition

1 Healthcare 99.06%
2 Financials 0.62%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
TIL icon
26
Instil Bio
TIL
$196M
$87.1M 1.21%
243,540
– –
CLDX icon
27
Celldex Therapeutics
CLDX
$1.57B
$86.4M 1.2%
+1,600,000
New +$86.4M
KNTE
28
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$82.7M 1.15%
3,593,052
– –
HOWL icon
29
Werewolf Therapeutics
HOWL
$62.6M
$73.6M 1.02%
4,291,881
– –
TNYA icon
30
Tenaya Therapeutics
TNYA
$192M
$73.3M 1.02%
+3,551,508
New +$73.3M
PNT
31
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$68.1M 0.94%
8,856,018
+7,757,700
+706% +$59.7M
GHRS icon
32
GH Research
GHRS
$870M
$66.5M 0.92%
3,013,957
+35,002
+1% +$772K
RYTM icon
33
Rhythm Pharmaceuticals
RYTM
$6.75B
$63.6M 0.88%
4,871,067
– –
RCKT icon
34
Rocket Pharmaceuticals
RCKT
$358M
$63M 0.87%
2,107,149
– –
CCCC icon
35
C4 Therapeutics
CCCC
$182M
$61.6M 0.85%
1,377,569
– –
CNTA
36
Centessa Pharmaceuticals
CNTA
$2.13B
$59.7M 0.83%
3,577,094
+2,296,794
+179% +$38.4M
OLMA icon
37
Olema Pharmaceuticals
OLMA
$432M
$59.3M 0.82%
2,150,404
– –
CYT
38
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$58.8M 0.81%
3,350,506
+103,389
+3% +$1.81M
PMVP icon
39
PMV Pharmaceuticals
PMVP
$82.1M
$51M 0.71%
1,710,265
– –
ZGNX
40
DELISTED
Zogenix, Inc.
ZGNX
$50.6M 0.7%
3,333,700
-1,950,276
-37% -$29.6M
DYN icon
41
Dyne Therapeutics
DYN
$1.92B
$45.6M 0.63%
2,805,045
– –
LENZ
42
LENZ Therapeutics
LENZ
$1.12B
$44.2M 0.61%
385,481
– –
EWTX icon
43
Edgewise Therapeutics
EWTX
$1.54B
$43.4M 0.6%
2,613,623
– –
VERV
44
DELISTED
Verve Therapeutics
VERV
$41.4M 0.57%
880,284
– –
GERN icon
45
Geron
GERN
$893M
$41.3M 0.57%
30,126,299
– –
ACHL
46
DELISTED
Achilles Therapeutics plc American Depositary Shares
ACHL
$39.1M 0.54%
5,014,687
– –
RXST icon
47
RxSight
RXST
$364M
$38.7M 0.54%
+3,052,796
New +$38.7M
WVE icon
48
Wave Life Sciences
WVE
$1.27B
$38.1M 0.53%
7,775,207
– –
KALV icon
49
KalVista Pharmaceuticals
KALV
$713M
$33.7M 0.47%
1,930,322
– –
DSGN icon
50
Design Therapeutics
DSGN
$339M
$32.1M 0.45%
2,186,636
– –
1
2
3 4 5